DE69627202D1 - Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht - Google Patents

Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht

Info

Publication number
DE69627202D1
DE69627202D1 DE69627202T DE69627202T DE69627202D1 DE 69627202 D1 DE69627202 D1 DE 69627202D1 DE 69627202 T DE69627202 T DE 69627202T DE 69627202 T DE69627202 T DE 69627202T DE 69627202 D1 DE69627202 D1 DE 69627202D1
Authority
DE
Germany
Prior art keywords
red blood
phthalocyanine
blood cells
red
blood cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69627202T
Other languages
English (en)
Other versions
DE69627202T2 (de
Inventor
Ehud Ben-Hur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Application granted granted Critical
Publication of DE69627202D1 publication Critical patent/DE69627202D1/de
Publication of DE69627202T2 publication Critical patent/DE69627202T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/052—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy infrared
DE69627202T 1995-11-06 1996-11-04 Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht Expired - Lifetime DE69627202T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US730695P 1995-11-06 1995-11-06
PCT/US1996/017528 WO1997016966A1 (en) 1995-11-06 1996-11-04 Viral inactivation treatment of red blood cells using phthalocyanines and red light

Publications (2)

Publication Number Publication Date
DE69627202D1 true DE69627202D1 (de) 2003-05-08
DE69627202T2 DE69627202T2 (de) 2003-11-13

Family

ID=21725402

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627202T Expired - Lifetime DE69627202T2 (de) 1995-11-06 1996-11-04 Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht

Country Status (8)

Country Link
US (1) US6090599A (de)
EP (1) EP0881874B1 (de)
JP (1) JP2000500137A (de)
AT (1) ATE235814T1 (de)
AU (1) AU723016B2 (de)
CA (1) CA2236873A1 (de)
DE (1) DE69627202T2 (de)
WO (1) WO1997016966A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767123B1 (fr) 1997-08-05 1999-10-29 Schmalbach Lubeca Pet Centre T Nouvelle structure de recipient et procede de conditionnement d'un produit au moyen de ce recipient
WO1999034839A1 (en) 1998-01-06 1999-07-15 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US20030180291A1 (en) * 1998-06-23 2003-09-25 Johnny Van Steveninck Method of inactivating viruses
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines
PT2130554E (pt) 1999-02-22 2012-11-19 Univ Connecticut Formulações de factor viii isentas de albumina
US6409719B1 (en) 2000-09-18 2002-06-25 Don A. Manning Light stint implant device for treatment of long term viral infection
CN103961731B (zh) 2004-10-29 2017-01-18 塞鲁斯公司 用于红细胞灭活过程的改进的猝灭方法
CN102046006B (zh) 2008-04-09 2014-09-24 塞鲁斯公司 用于红细胞病原体灭活的改进猝灭方法
US20100168018A1 (en) 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
EP2645854B1 (de) 2010-11-29 2017-10-18 New York Blood Center, Inc. Verfahren zur sammlung und lagerung von blut

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
CN1039283C (zh) * 1988-12-12 1998-07-29 Fmc公司 卟啉的应用
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5516629A (en) * 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
DK0660712T3 (da) * 1992-09-21 2001-08-27 Quadra Logic Tech Inc Transcutation in vivo-aktivering af lysfølsomme midler i blod
EP0680365B1 (de) * 1992-11-20 2000-03-01 The University Of British Columbia Aktivierung von photoempfindlichen mitteln
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases

Also Published As

Publication number Publication date
EP0881874B1 (de) 2003-04-02
CA2236873A1 (en) 1997-05-15
EP0881874A1 (de) 1998-12-09
AU7667296A (en) 1997-05-29
DE69627202T2 (de) 2003-11-13
US6090599A (en) 2000-07-18
WO1997016966A1 (en) 1997-05-15
EP0881874A4 (de) 2000-09-27
AU723016B2 (en) 2000-08-17
JP2000500137A (ja) 2000-01-11
ATE235814T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DE69627202T2 (de) Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht
DE68915834D1 (de) Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten.
ATE300298T1 (de) Behandlung von leukocyten durch photopheresis
NO972538L (no) Nye sulfonamider
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
FI951516A0 (fi) Menetelmä paperin värjäämiseksi
Kelland et al. An action spectrum for ultraviolet radiation‐induced membrane damage in Escherichia coli K‐12
DE69232417T2 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69328102D1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
Arase et al. The effects of light and photo‐and protein‐synthetic inhibitors on the Sekiguchi lesion formation by Magnaporthe grisea in rice cv. Sekiguchi‐asahi
Suzaki et al. Photoresponse of a colorless euglenoid flagellate, Astasia longa
ATE106899T1 (de) Inhibitor der proliferation von endothelzellen.
Lerman et al. Prevention of direct and photosensitized ultraviolet radiation damage to the ocular lens
ATE224190T1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
DE69227899D1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
ATE264112T1 (de) Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus
Togashi et al. Effects of UV‐irradiation at Various Wavelengths on Sterilizing Drosophila Embryos: (Drosophila embryo/UV‐effects/pole cells/polar plasm/nucleic acids)
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
Uzdensky Participation of some radical products in isolated nerve cell response to blue laser microirradiation
DE3678820D1 (de) Verwendung einer loesung von alpha-chymotrypsin.
Crystal Sexual sterilization of insects by aerosol administration of alkylating agents
DE69626276T2 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
DE59701514D1 (de) Verfahren zur bestimmung der phototoxizität und/oder photosensibilität von stoffen oder stoffgemischen sowie dessen verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition